Mary Q Xu

Title: Mary Q Xu: Innovator in Cancer Treatment

Introduction

Mary Q Xu is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents. Her work focuses on targeting specific proteins associated with various cancers, showcasing her dedication to advancing medical science.

Latest Patents

Mary Q Xu holds a patent for the invention titled "Anti-PODXL antibody MAI1738 and its use for cancer treatment." This patent provides a therapeutic agent designed for the treatment, prevention, and diagnosis of cancers linked to cells that overexpress podocalyxin-like protein precursor isoform 2 (PODXL-v2) and its variants. The invention is particularly relevant for gastric cancers, prostate cancer, and several other malignancies. The agent is based on the amino acid sequences of the novel light chain variable regions of an anti-PODXL-v2 monoclonal antibody (mAb), MAb1738, which has shown efficacy in inhibiting the proliferation of human cancer cell lines and reducing the growth and metastasis of gastric cancer in mouse models. Mary has a total of 1 patent to her name.

Career Highlights

Mary Q Xu is currently associated with Medabome, Inc., where she continues her groundbreaking work in cancer research. Her career is marked by a commitment to developing innovative solutions that address critical health challenges.

Collaborations

Mary has collaborated with notable colleagues, including Yinghui Rong and Mason Lu, to further her research initiatives. These collaborations have enhanced the scope and impact of her work in the field of oncology.

Conclusion

Mary Q Xu is a trailblazer in the realm of cancer treatment, with her innovative patent contributing to the fight against various forms of cancer. Her dedication to research and collaboration underscores her significant role in advancing medical science.